drugset / Trial / NCT00813020
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this clinical trial is to investigate whether differences exist between three different concentrations of the drug, NN9535, administered in healthy male subjects in equal doses.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 1 mg/ml | Subcutaneous |
| Subject | Semaglutide | Peptide | 3 mg/ml | Subcutaneous |
| Subject | Semaglutide | Peptide | 10 mg/ml | Subcutaneous |